Wilfried Posch (W Posch)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

Microorganisms

Journal of fungi (Basel, Switzerland)

Microbiology spectrum

European journal of immunology

Medizinische Universität Innsbruck

UCL (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medizinische Universität Innsbruck Feb 01 2015

Austria

Senior Scientist/Ass.-Prof. :: Institut für Hygiene und Medizinische Mikrobiologie

Medizinische Universität Innsbruck Jan 01 2010 - Feb 01 2015

Austria

Post-Doc :: Institut für Hygiene und Medizinische Mikrobiologie

INSERM UMR S 945 Jun 01 2011 - Jan 01 2012

France

Post-Doc (visiting) :: Faculte de Medecine

Medizinische Universität Innsbruck Jul 01 2007 - Jan 01 2010

Austria

PhD Student :: Institut für Hygiene und Medizinische Mikrobiologie

University College London Aug 01 2008 - Jun 01 2009

United Kingdom

PhD Student (visiting) :: Division of Infection and Immunity

Education History

UCL Aug 01 2008 - Jun 01 2009

United Kingdom

PHD :: Division of Infection and Immunity

Publications

Christoph Schatz, Ludwig Knabl, Hye Kyung Lee, Rita Seeboeck, Dorothee von Laer, Eliott Lafon, Wegene Borena, Harald Mangge, Florian Prüller, Adelina Qerimi, Doris Wilflingseder, Wilfried Posch, Johannes Haybaeck
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants. Microorganisms 12 (4) (2024)
Stefanie Dichtl, Wilfried Posch, Doris Wilflingseder
The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung-on-chip. European journal of immunology 54 (3) (2024)
Christoph Schatz, Ludwig Knabl, Hye Kyung Lee, Rita Seeboeck, Dorothee von Laer, Eliott Lafon, Wegene Borena, Harald Mangge, Florian Prüller, Adelina Qerimi, Doris Wilflingseder, Wilfried Posch, Johannes Haybaeck
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants. Microorganisms 12 (4) (2024)
Stefanie Dichtl, Wilfried Posch, Doris Wilflingseder
The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung-on-chip. European journal of immunology 54 (3) (2024)
Stefanie Dichtl, Wilfried Posch, Doris Wilflingseder
The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung-on-chip. European journal of immunology (2024)
Astrid I Knell, Anna K Böhm, Michael Jäger, Julia Kerschbaum, Sabine Engl, Michael Rudnicki, Lukas Buchwinkler, Rosa Bellmann-Weiler, Wilfried Posch, Guenter Weiss
Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients. Microorganisms 11 (7) (2023)
Gabriel Diem, Michael Jäger, Stefanie Dichtl, Angelika Bauer, Cornelia Lass-Flörl, Markus Reindl, Doris Wilflingseder, Wilfried Posch
Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5. Microbiology spectrum (2023)
Gabriel Diem, Stefanie Dichtl, Viktoria Zaderer, Cornelia Lass-Flörl, Markus Reindl, Gaia Lupoli, Christopher Dächert, Maximilian Muenchhoff, Alexander Graf, Helmut Blum, Oliver T Keppler, Doris Wilflingseder, Wilfried Posch
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern. Microbiology spectrum (2023)
Michael Jäger, Gabriel Diem, Sabina Sahanic, Vilmos Fux, Andrea Griesmacher, Cornelia Lass-Flörl, Doris Wilflingseder, Amra Tancevski, Wilfried Posch
Immunity of heterologous and homologous boosted or convalescent individuals against Omicron BA.1, BA.2 and BA.4/5 variants. The Journal of infectious diseases (2023)
Giulia Bertacchi, Wilfried Posch, Doris Wilflingseder
HIV-1 Trans Infection via TNTs Is Impeded by Targeting C5aR. Biomolecules 12 (2) (2022)
Cornelia Lass-Flörl, Miriam Knoll, Wilfried Posch, Michael Joannidis, Timo Mayerhoefer, Robert Breitkopf, Romuald Bellmann
A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data. Diagnostics (Basel, Switzerland) 13 (1) (2022)
Sissy Therese Sonnleitner, Martina Prelog, Stefanie Sonnleitner, Eva Hinterbichler, Hannah Halbfurter, Dominik B C Kopecky, Giovanni Almanzar, Stephan Koblmueller, Christian Sturmbauer, Leonard Feist, Ralf Horres, Wilfried Posch, Gernot Walder
Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host. Nature communications 13 (1) (2022)
Cornelia Lass-Flörl, Miriam Knoll, Wilfried Posch, Michael Joannidis, Timo Mayerhoefer, Robert Breitkopf, Romuald Bellmann
A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data. Diagnostics (Basel, Switzerland) 13 (1) (2022)
Michael Jäger, Stefanie Dichtl, Rosa Bellmann-Weiler, Markus Reindl, Cornelia Lass-Flörl, Doris Wilflingseder, Wilfried Posch
Serum neutralization against SARS-CoV-2 variants is heterogenic and depends on vaccination regimen. The Journal of infectious diseases (2022)
Nina Lackner, Claudius Thomé, Dietmar Öfner-Velano, Michael Joannidis, Timo Mayerhoefer, Rohit Arora, Eldina Samardzic, Wilfried Posch, Robert Breitkopf, Cornelia Lass-Flörl
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility. Journal of fungi (Basel, Switzerland) 8 (2) (2022)
Alexander E Egger, Sabina Sahanic, Andreas Gleiss, Franz Ratzinger, Barbara Holzer, Christian Irsara, Nikolaus Binder, Christoph Winkler, Christoph J Binder, Wilfried Posch, Lorin Loacker, Boris Hartmann, Markus Anliker, Guenter Weiss, Thomas Sonnweber, Ivan Tancevski, Andrea Griesmacher, Judith Löffler-Ragg, Gregor Hoermann
One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies. Microbiology spectrum (2022)
Cornelia Lass-Flörl, Miriam Knoll, Wilfried Posch, Michael Joannidis, Timo Mayerhoefer, Robert Breitkopf, Romuald Bellmann
A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data. Diagnostics (Basel, Switzerland) 13 (1) (2022)
Gabriel Diem, Eliott Lafon, Angelika Bauer, Cornelia Lass-Flörl, Markus Reindl, Doris Wilflingseder, Wilfried Posch
Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern. Journal of clinical microbiology 60 (9) (2022)
Sissy Therese Sonnleitner, Martina Prelog, Bianca Jansen, Chantal Rodgarkia-Dara, Sarah Gietl, Carmen Maria Schönegger, Stephan Koblmueller, Christian Sturmbauer, Wilfried Posch, Giovanni Almanzar, Hanna Jury, Tom Loney, Alexander Tichy, Norbert Nowotny, Gernot Walder
Maintenance of neutralizing antibodies over ten months in convalescent SARS-CoV-2 afflicted patients. Transboundary and emerging diseases (2021)
Maureen K Luvanda, Wilfried Posch, Jonathan Vosper, Viktoria Zaderer, Asma Noureen, Cornelia Lass-Flörl, Doris Wilflingseder
Dexamethasone Promotes Aspergillus fumigatus Growth in Macrophages by Triggering M2 Repolarization via Targeting PKM2. Journal of fungi (Basel, Switzerland) 7 (2) (2021)
Wilfried Posch, J Vosper, V Zaderer, A Noureen, S Constant, R Bellmann-Weiler, Cornelia Lass-Flörl, Doris Wilflingseder
ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia. mBio 12 (2) (2021)
Maureen K Luvanda, Wilfried Posch, Asma Noureen, Eliott Lafon, Viktoria Zaderer, Cornelia Lass-Flörl, Doris Wilflingseder
Dexamethasone Creates a Suppressive Microenvironment and Promotes Aspergillus fumigatus Invasion in a Human 3D Epithelial/Immune Respiratory Model. Journal of fungi (Basel, Switzerland) 7 (3) (2021)
Stefanie Wunsch, Christoph Zurl, Heimo Strohmaier, Andreas Meinitzer, Jasmin Rabensteiner, Wilfried Posch, Cornelia Lass-Flörl, Oliver Cornely, Gudrun Pregartner, Elisabeth König, Gebhard Feierl, Martin Hoenigl, Juergen Prattes, Ines Zollner-Schwetz, Thomas Valentin, Robert Krause
Longitudinal Evaluation of Plasma Cytokine Levels in Patients with Invasive Candidiasis. Journal of fungi (Basel, Switzerland) 7 (2) (2021)
Nina Lackner, Wilfried Posch, Cornelia Lass-Flörl
Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New. Microorganisms 9 (7) (2021)
Viktoria Zaderer, Wilfried Posch, Ronald Gstir, Przemyslaw A Filipek, Günther K Bonn, Pornanong Aramwit, Lukas A Huber, Doris Wilflingseder
P80 Natural Essence Exerts Efficient Anti-HIV-1- as Well as Adjuvant Effects in DCs. Vaccines 9 (9) (2021)
Sára Kellnerová, Sneha Chatterjee, Rafael Bayarri-Olmos, Louise Justesen, Heribert Talasz, Wilfried Posch, Samyr Kenno, Peter Garred, Dorothea Orth-Höller, Marco Grasse, Reinhard Würzner
Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines. Toxins 13 (1) (2020)
Marion Steger, Marta Bermejo-Jambrina, Teodor Yordanov, Johannes Wagener, Axel A Brakhage, Verena Pittl, Lukas A Huber, Hubertus Haas, Cornelia Lass-Flörl, Wilfried Posch, Doris Wilflingseder
β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cells. Virulence 10 (1) (2018)
P Chandorkar, Wilfried Posch, V Zaderer, M Blatzer, M Steger, C G Ammann, U Binder, M Hermann, P Hörtnagl, C Lass-Flörl, Doris Wilflingseder
Fast-track development of an in vitro 3D lung/immune cell model to study Aspergillus infections. Scientific reports 7 (1) (2017)

Wilfried Posch.css-eqlu8i{font-size:small;padding-left:4px;} (W Posch)

Publication Activity (10 Years)

Top Topics

Top Venues

Wilfried Posch (W Posch)